Integrated Suicide Supports and Safety Planning for Youth (ISSP)

May 14, 2026 updated by: Laura Richardson, University of Washington

Integrated Screening and Safety Planning (ISSP) for Adolescents With Suicidal Thoughts

The goal of this clinical trial is to evaluate an app to help keep teens and young adults with suicidal thoughts safe. The app includes a safety plan created by adolescents and healthcare providers, and videos to encourage supportive communication and skills for teens and young adults to stay safe. The main question it aims to answer is whether the use of an app can increase youth suicide-related coping for youth with suicidal ideation, parent/caregiver suicide prevention self-efficacy, and healthcare provider self-efficacy in suicide management. Researchers will compare usual care to usual care with the app. Participants, including adolescents, caregivers, and healthcare providers, will use the ISSP app (if assigned to that group) and view video content and complete three online surveys.

Study Overview

Status

Recruiting

Detailed Description

The current study aims to evaluate the Jaspr app relative to usual care among youth (ages 13-21 years) who indicate suicidal ideation in pediatric medical settings. The Jaspr app includes supported safety planning between the young person and the healthcare provider, as well as skills and support videos for youth and caregivers intended to increase coping and decrease distress with an opportunity to access these resources through an at home app. Adolescents, parents, and clinicians will participate in the project to assess the effectiveness of Jaspr augmenting usual care, compared to usual care alone. The study will use a pre-post design in which each setting begins with a control period and then transitions to the addition of Jaspr following healthcare provider training on use of the app. Participants and their parents/caregivers will receive study assessments at baseline, 1-month, and 2-month follow up timepoints, and healthcare providers complete a survey at baseline, and the end of each period (control and intervention). Study assessments with youth will ask about coping, suicidal ideation and severity, anxiety and depression, service utilization, functional impairment, access to lethal means, and acceptability of the app. Study assessments for parents/caregivers will ask about their self-efficacy in managing their youth's suicidality, acceptability of the videos/app, and service utilization for the youth. Healthcare providers will complete surveys assessing their self-efficacy in managing youth suicidality and feasibility of use of the app. Youth, their legal guardian, and healthcare providers each assent/consent to participate in the research procedures.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Laura Richardson, MD, MPH
  • Phone Number: 206-987-2028
  • Email: lpr@uw.edu

Study Locations

    • Washington
      • Seattle, Washington, United States, 98115
        • Recruiting
        • Seattle Children's Hospital
        • Contact:
        • Principal Investigator:
          • Laura Richardson, MD MPH
        • Principal Investigator:
          • Cari McCarty, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Youth Inclusion Criteria:

  • Age 13 -21 years, an Ask Suicide Questions (ASQ) screen score of 1-5 with active ideation (not solely a history of a prior attempt) but no current plan or intent, or patient-reported suicidal thoughts and behaviors during a clinical assessment in a medical setting who are judged by a clinician to be appropriate for conducting higher level assessment in that setting (including a BSSA and/or safety planning) in order to support care at home.
  • Parents/guardians: One "parent" per AYA will also be invited to participate.
  • HCPs: All HCPs in participating settings who may conduct assessments of SI and safety planning (physicians, nurse practitioners/physician's assistants, social workers, mental health counselors, psychologists) will be invited to participate.
  • All subjects must have access to the internet and a computer or tablet device.

Youth Exclusion Criteria:

  • Concurrently enrolled in an affiliated Suicide Care Research Center study, no phone access, or non-English speaking.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Care
Experimental: Integrated skills and safety planning app
Use of Jaspr app for clinical care + at home
This is a digital app that includes supported safety planning resources in medical settings as well as coping skills and lived experience videos for adolescents, young adults and parents/caregivers that can be accessed while in the medical setting or at home.
Other Names:
  • Jaspr

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth Suicide-Related Coping
Time Frame: Baseline, 1 month, 2 month
Total Score on the 17-item Youth Suicide-Related Coping Scale
Baseline, 1 month, 2 month
Parent suicide prevention self-efficacy
Time Frame: Baseline, 1 month, 2 month
Total score on the Parent suicide prevention self-efficacy scale
Baseline, 1 month, 2 month
Healthcare provider self-efficacy in suicide management
Time Frame: Baseline, end of control period, and end of intervention period
Total score on the Provider suicide Intervention Questionnaire
Baseline, end of control period, and end of intervention period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Youth Suicide Severity
Time Frame: Baseline, 1 month, 2 month
Total score on the online self-report version of the Columbia Suicide Severity Rating Scale (C-SSRS)
Baseline, 1 month, 2 month
Youth Anxiety Symptoms
Time Frame: Baseline, 1 month, 2 month
Total Score on Youth Self-Reported Generalized Anxiety Disorder -7 item scale
Baseline, 1 month, 2 month
Intervention Acceptability
Time Frame: Baseline, 1 month, 2 month
Youth and Parent Report on the Acceptability of Intervention Measure (AIM)
Baseline, 1 month, 2 month
Functional Impairment
Time Frame: Baseline, 1 month, 2 month
Total score on the youth reported EQ-5D-Y quality of life measure
Baseline, 1 month, 2 month
Youth Suicidal ideation
Time Frame: Baseline, 1 month, 2 month
Total Score on the Harkavy Asnis Suicide Scale ideation subscale (HASS-I),
Baseline, 1 month, 2 month
Youth Depressive Symptoms
Time Frame: Baseline, 1 month, 2 month
Total score on the Patient Health Questionnaire 9
Baseline, 1 month, 2 month
Safety Plan Quality
Time Frame: Up to 1 month
Safety Planning Scoring Algorithm (SPISA) based on youth medical chart review
Up to 1 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention Feasibility
Time Frame: Baseline, 1 month, 2 month
Healthcare Provider Report on the Feasibility of Intervention Measure (FIM)
Baseline, 1 month, 2 month
Mental Health Services Use
Time Frame: Baseline, 2 months
Dichotomous rating of any mental health service use following baseline using chart review or indication based on parent or youth report on the Services Assessment for Children and Adolescents (SACA)
Baseline, 2 months
Access to Lethal Means
Time Frame: 1 month
BRFSS Module 17 - Youth report of access to a firearm
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Richardson, MD, MPH, University of Washington

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 19, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Study Registration Dates

First Submitted

November 20, 2024

First Submitted That Met QC Criteria

November 20, 2024

First Posted (Actual)

November 22, 2024

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 14, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00020199
  • P50MH129708 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We plan to share required elements with the NIMH NDA.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Ideation

Clinical Trials on Integrated skills and safety planning app

Subscribe